EYEGATE PHARMACEUTICALS INC (33) | Business Finance (15)

Browse by Subcategory

Recent Contracts

Stock Purchase Agreement, dated as of October 21, 2021, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein (Filed With SEC on October 26, 2021)
Form of Placement Agent Warrant (Filed With SEC on August 10, 2021)
Form of Securities Purchase Agreement (Filed With SEC on August 10, 2021)
Patent and Know How Assignment Agreement, dated as of July 2, 2013, by and between Panoptes Pharma Ges.m.b.H and 4SC Discovery GmbH (Filed With SEC on March 25, 2021)
Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021 (Filed With SEC on January 6, 2021)
Share Purchase Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein (Filed With SEC on December 21, 2020)
Form of Warrant (Filed With SEC on August 10, 2021)
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of January 5, 2021 (Filed With SEC on January 6, 2021)
Form of Warrant (Filed With SEC on January 6, 2021)
Registration Rights Agreement, dated as of December 18, 2020, by and among EyeGate Pharmaceuticals, Inc. and the Sellers listed therein (Filed With SEC on December 21, 2020)
Form of Placement Agent Warrant (Filed With SEC on December 31, 2019)
Form of Securities Purchase Agreement (Filed With SEC on December 31, 2019)
Form of Warrant (Filed With SEC on September 30, 2019)
Securities Purchase Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019 (Filed With SEC on September 30, 2019)
Registration Rights Agreement between the Company and Armistice Capital Master Fund, Ltd. dated as of September 29, 2019 (Filed With SEC on September 30, 2019)